➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Moodys
Express Scripts
AstraZeneca
Merck

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pyridoxal Phosphate

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Pyridoxal Phosphate?

Pyridoxal Phosphate is an investigational drug.

There have been 4 clinical trials for Pyridoxal Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2011.

The most common disease conditions in clinical trials are Movement Disorders, Dyskinesias, and Protoporphyria, Erythropoietic. The leading clinical trial sponsors are University of California, San Francisco, University of Alabama at Birmingham, and Beersheva Mental Health Center.

There are two US patents protecting this investigational drug and twenty international patents.

Recent Clinical Trials for Pyridoxal Phosphate
TitleSponsorPhase
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaIcahn School of Medicine at Mount SinaiN/A
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)N/A
Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic ProtoporphyriaUniversity of Alabama at BirminghamN/A

See all Pyridoxal Phosphate clinical trials

Clinical Trial Summary for Pyridoxal Phosphate

Top disease conditions for Pyridoxal Phosphate
Top clinical trial sponsors for Pyridoxal Phosphate

See all Pyridoxal Phosphate clinical trials

US Patents for Pyridoxal Phosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pyridoxal Phosphate   Start Trial Bone delivery conjugates and method of using same to target proteins to bone Alexion Pharmaceuticals, Inc. (New Haven, CT)   Start Trial
Pyridoxal Phosphate   Start Trial Topical emulsions comprising indium tin oxide coated particles ELC Management LLC (Melville, NY)   Start Trial
Pyridoxal Phosphate   Start Trial Particle detecting device AZBIL CORPORATION (Chiyoda-ku, JP)   Start Trial
Pyridoxal Phosphate   Start Trial Dietary supplement and methods of use Inovobiologic Inc. (Calgary, CA)   Start Trial
Pyridoxal Phosphate   Start Trial Method of treatment HEXIMA LIMITED (Bundoora, AU)   Start Trial
Pyridoxal Phosphate   Start Trial Inhibitors of beta integrin-G protein alpha subunit binding interactions THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (Urbana, IL)   Start Trial
Pyridoxal Phosphate   Start Trial Systems and methods for fluid and component handling Theranos IP Company, LLC (Newark, CA)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pyridoxal Phosphate

Drugname Country Document Number Estimated Expiration Related US Patent
Pyridoxal Phosphate Austria 505551 2024-04-21   Start Trial
Pyridoxal Phosphate Australia 2005235635 2024-04-21   Start Trial
Pyridoxal Phosphate Canada 2559228 2024-04-21   Start Trial
Pyridoxal Phosphate Germany 602005027461 2024-04-21   Start Trial
Pyridoxal Phosphate Denmark 1759001 2024-04-21   Start Trial
Pyridoxal Phosphate Denmark 2348114 2024-04-21   Start Trial
Pyridoxal Phosphate European Patent Office 1759001 2024-04-21   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Moodys
Express Scripts
AstraZeneca
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.